Evaluation of convalescent plasma for Ebola virus disease in Guinea

New England Journal of Medicine

Volumn 374, Issue 1, 2016, Pages 33-42

  Van Griensven, J ^a   Edwards, T ^d   De Lamballerie, X ^g,h,i,j   Semple, M G ^e   Gallian, P ^g,j,k   Baize, S ^l   Horby, P W ^f   Raoul, H ^m   Magassouba, N ^o   Antierens, A ^b   Lomas, C ^b   Faye, O ^s   Sall, A A ^s   Fransen, K ^a   Buyze, J ^a   Ravinetto, R ^a,c   Tiberghien, P ^k,n   Claeys, Y ^a   De Crop, M ^a   Lynen, L ^a   Bah, E I ^p   Smith, P G ^d   Delamou, A ^r   De Weggheleire, A ^a   Haba, N ^q   more..

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b MÉDECINS SANS FRONTIÈRES   (Belgium)

^c DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g AIX MARSEILLE UNIVERSITY   (France)

^h French Institute of Research for Development   (France)

ⁱ EHESP SCHOOL OF PUBLIC HEALTH   (France)

^j Institut Hospitalo Universitaire Méditerranée Infection   (France)

^k ETABLISSEMENT FRANÇAIS DU SANG   (France)

^l CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^m INSERM   (France)

ⁿ UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^o Université Gamal Abdel Nasser de Conakry   (Guinea)

^p Donka National Hospital   (Guinea)

^q National Blood Transfusion Center   (Guinea)

^r National Center for Training and Research in Rural Health of Maferinyah   (Guinea)

^s INSTITUT PASTEUR DE DAKAR   (Senegal)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ADOLESCENT; ADULT; ADVERSE EFFECTS; BLOOD; BLOOD COMPONENT THERAPY; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONVALESCENCE; EBOLAVIRUS; FEMALE; GUINEA; HEMORRHAGIC FEVER, EBOLA; HUMAN; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; PLASMA; PREGNANCY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, NEUTRALIZING; BLOOD COMPONENT TRANSFUSION; CHILD; CHILD, PRESCHOOL; CONVALESCENCE; EBOLAVIRUS; FEMALE; GUINEA; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFANT; MALE; MIDDLE AGED; ODDS RATIO; PLASMA; PREGNANCY; YOUNG ADULT;

EID: 84954049384     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1511812     Document Type: Article

References (16)

1. World Health Organization. Ebola situation report - September 9, 2015 (http://apps.who.int/ebola/current-situation/ebola-situation-report-9-september-2015).
2. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014;371:2092-100.
3. Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2015;372:40-7.
4. Interim guidance for national health authorities and blood transfusion services: use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks. Geneva: World Health Organization, 2014.
5. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 2015;211:80-90.
6. Casadevall A, Dadachova E, Pirofski LA. Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2004;2:695-703.
7. Mupapa K, Massamba M, Kibadi K, et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis 1999;179:Suppl 1:S18-23.
8. Adebamowo C, Bah-Sow O, Binka F, et al. Randomised controlled trials for Ebola: practical and ethical issues. Lancet 2014;384:1423-4.
9. Sterck A, Médecins sans Frontières. Filovirus haemorrhagic fever guideline. 2008 (www.medbox.org/filovirus-haemorrhagic-fever-guideline/download.pdf).
10. Agua-Agum J, Ariyarajah A, Blake IM, et al. Ebola virus disease among children in West Africa. N Engl J Med 2015;372:1274-7.
11. Favipiravir in patients with Ebola virus disease: early results of the JIKI trial in Guinea. Presented at the Conference on Retroviruses and Opportunistic Infections, Seattle, February 23-26, 2015 (http://www.croiwebcasts.org/console/player/25697).
12. Norton EC, Miller MM, Kleinman LC. Computing adjusted risk ratios and risk differences in Stata. Stata J 2013;13:492-509.
13. Qiu X, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014;514:47-53.
14. Dye JM, Herbert AS, Kuehne AI, et al. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci U S A 2012;109:5034-9.
15. Mupapa K, Mukundu W, Bwaka MA, et al. Ebola hemorrhagic fever and pregnancy. J Infect Dis 1999;179:Suppl 1:S11-2.
16. Mora-Rillo M, Arsuaga M, Ramírez-Olivencia G, et al. Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain. Lancet Respir Med 2015;3:554-62.